Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 22.17 | 15.81 | 40 |
OPM % | 23.14 | 16.45 | - |
PBDT | 4.63 | 2.19 | 111 |
PBT | 4.45 | 1.98 | 125 |
NP | 4.36 | 1.67 | 161 |